These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14654065)

  • 1. Cytochrome P450: major player in reperfusion injury.
    Gottlieb RA
    Arch Biochem Biophys; 2003 Dec; 420(2):262-7. PubMed ID: 14654065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of cytochrome p450 in ischemic heart disease.
    Sato M; Yokoyama U; Fujita T; Okumura S; Ishikawa Y
    Curr Drug Metab; 2011 Jul; 12(6):526-32. PubMed ID: 21476972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity.
    Caro AA; Cederbaum AI
    Free Radic Biol Med; 2006 Feb; 40(3):364-75. PubMed ID: 16443151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pathophysiological role of cytochrome p450 involved in production of reactive oxygen species].
    Shimamoto N
    Yakugaku Zasshi; 2013; 133(4):435-50. PubMed ID: 23546588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.
    Granville DJ; Tashakkor B; Takeuchi C; Gustafsson AB; Huang C; Sayen MR; Wentworth P; Yeager M; Gottlieb RA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1321-6. PubMed ID: 14734800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.
    Barau C; Ghaleh B; Berdeaux A; Morin D
    Fundam Clin Pharmacol; 2015 Feb; 29(1):1-9. PubMed ID: 24990103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
    Gross GJ; Falck JR; Gross ER; Isbell M; Moore J; Nithipatikom K
    Cardiovasc Res; 2005 Oct; 68(1):18-25. PubMed ID: 15993870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of eicosanoids in the ischemic and reperfused myocardium.
    Bend JR; Karmazyn M
    EXS; 1996; 76():243-62. PubMed ID: 8805799
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
    Nithipatikom K; Gross ER; Endsley MP; Moore JM; Isbell MA; Falck JR; Campbell WB; Gross GJ
    Circ Res; 2004 Oct; 95(8):e65-71. PubMed ID: 15388642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.
    Ishihara Y; Sekine M; Hamaguchi A; Kobayashi Y; Harayama T; Nakazawa M; Shimamoto N
    J Pharmacol Sci; 2010; 113(4):335-42. PubMed ID: 20644334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.
    Ishihara Y; Sekine M; Nakazawa M; Shimamoto N
    Eur J Pharmacol; 2009 Jun; 611(1-3):64-71. PubMed ID: 19356728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species.
    Khan M; Mohan IK; Kutala VK; Kumbala D; Kuppusamy P
    J Pharmacol Exp Ther; 2007 Dec; 323(3):813-21. PubMed ID: 17873104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
    Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
    Spiecker M; Liao JK
    Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
    Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
    Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of cytochrome P450 induced by proteasome inhibition during cardiac ischemia.
    Ishihara Y; Hamaguchi A; Sekine M; Hirakawa A; Shimamoto N
    Arch Biochem Biophys; 2012 Nov; 527(1):16-22. PubMed ID: 22885143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beating ischemia: a new feat of EETs?
    Bhatnagar A
    Circ Res; 2004 Sep; 95(5):443-5. PubMed ID: 15345665
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
    Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
    J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Arachidonic Acid Metabolism in Myocardial Ischemia-Reperfusion Injury.
    Zhang C; He M; Ni L; He K; Su K; Deng Y; Li Y; Xia H
    Cell Biochem Biophys; 2020 Sep; 78(3):255-265. PubMed ID: 32623640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.